Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial

Linda Stein Gold, David N. Adam, Lorne Albrecht, Javier Alonso‐Llamazares, Laura K. Ferris, Melinda Gooderham, Hwanhee Hong, Steven Kempers, Leon Kircik, Mark Lebwohl, Wei Jing Loo, Walter K. Nahm, Kim Papp, Daniel Stewart, Darryl Toth, Matthew Zirwas, David Krupa, Scott Snyder, Patrick Burnett, Robert Higham, David R. Berk